Ömrüye Özok Arıcı | Cancer | Research Excellence Award

Published on by Research Chemistry Awards

Assist. Prof. Dr. Ömrüye Özok Arıcı | Cancer | Research Excellence Award

Eskişehir Osmangazi Üniversitesi | Turkey

Assist. Prof. Dr. Ömrüye Özok Arıcı is an academic researcher specializing at the interface of molecular biology, chemical engineering, and biomedical engineering. She completed her PhD in Molecular Biology and Genetics at Van Yüzüncü Yıl University, focusing on the synthesis of artemisinin–benzothiophene derivatives and the evaluation of their antimicrobial, antioxidant, and cytotoxic activities. She holds a master’s degree in Biology with research on Streptomyces species and enzyme production, and a bachelor’s degree in Biology. She further expanded her interdisciplinary expertise through postdoctoral research at Eskişehir Osmangazi University in the Department of Chemical Engineering. Since 2023, she has been serving as an Assistant Professor in the Department of Biomedical Engineering at Eskişehir Osmangazi University. Her research interests include medicinal and bioactive compound synthesis, antimicrobial and antioxidant studies, cytotoxicity assessment, and applied biomedical technologies. She has received institutional research support and recognition for her scientific contributions. Overall, her work reflects a strong commitment to interdisciplinary research addressing biomedical and chemical innovation.

Citation Metrics (Scopus)

200

150

100

50

0

 

Citations
173

Documents
20

h-index
8

                               Citations                    Documents                      h-index

View Scopus ProfileView Google Scholar Profile

Featured Publications

Taeyoon Jung | Biochemical Pharmacology | Research Excellence Award

Published on by Research Chemistry Awards

Dr. Taeyoon Jung | Biochemical Pharmacology | Research Excellence Award

University of Washington | United States

Dr. Taeyoon Jung is a medicinal chemist and trained pharmacist with strong expertise in drug metabolism and pharmacokinetics (DMPK), integrating experimental and computational approaches to advance drug discovery and safety evaluation. He earned his PhD in Medicinal Chemistry from the University of Washington, following an MS in Drug Evaluation and a PharmD from Chungnam National University. His academic and professional experience spans leading research universities and industry, including graduate research roles in medicinal chemistry, pharmacology, and molecular toxicology, as well as a DMPK graduate internship in a global biopharmaceutical company. Dr. Jung’s research focuses on hydrogen sulfide signaling in cardiac and hepatic stress models, species-dependent drug metabolism, toxicology of bioactivated metabolites, and structure–function relationships of metabolic enzymes. He is highly skilled in LC-MS/MS-based metabolite quantification, in vitro ADME systems, cell-based and molecular assays, and advanced computational modeling such as molecular docking, molecular dynamics, and metadynamics for inhibitor design. His work has contributed to multiple peer-reviewed publications in drug metabolism and toxicology. In recognition of his scientific excellence, he has received several competitive scholarships, endowed funds, and presentation awards. Overall, Dr. Jung’s interdisciplinary background bridges chemistry, pharmacology, and computation, positioning him as a versatile researcher dedicated to improving drug safety and therapeutic development.

View ORCID Profile

Featured Publications

Tushar Adhikari | Phytochemistry | Research Excellence Award

Published on by Research Chemistry Awards

Mr. Tushar Adhikari | Phytochemistry | Research Excellence Award

Guru Nanak Institute of Pharmaceutical Science and Technology | India

Mr. Tushar Adhikari is an emerging academic and researcher in the field of pharmaceutical sciences, with a strong foundation in pharmaceutical chemistry and phytochemistry. He completed his M.Pharm. with a specialization in Pharmaceutical Chemistry from Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, securing First Class Honours, following his B.Pharm. from Adamas University with First Class Honours. His academic journey reflects consistent excellence from secondary education through postgraduate studies. Since August 2022, he has been serving as an Assistant Professor at Guru Nanak Institute of Pharmaceutical Science and Technology, where he has accumulated over 1.5 years of teaching, research, and administrative experience. His research interests are primarily centered on phytochemistry, with hands-on expertise in extraction, fractionation, isolation, purification, and characterization of bioactive phytoconstituents, particularly flavonoids, using advanced chromatographic and spectroscopic techniques such as HPTLC, TLC, column chromatography, UV, IR, and AAS. In addition, he has exposure to computer-aided drug design, including molecular docking, 2D and 3D QSAR, and pharmacophore modeling. His academic distinctions, teaching contributions, and interdisciplinary research orientation highlight his commitment to advancing pharmaceutical education and research, positioning him as a promising contributor to future innovations in drug discovery and natural product research.

Citation Metrics (Scopus)

8
6
4
2
0

Citations
5

Documents
6

h-index
2

 

Citations

Documents

h-index

Featured Publications


Phytochemistry and Pharmacological Potential of Alocasia macrorrhiza: A Comprehensive Review

– Journal of Applied Pharmaceutical Research, 2024, Vol. 12 (Issue 6)

Camilla Djenne Buarque Muller | Medicinal Chemistry | Best Researcher Award

Published on by Research Chemistry Awards

Prof. Dr. Camilla Djenne Buarque Muller | Medicinal Chemistry | Best Researcher Award

PUC-Rio | Brazil

Prof. Dr. Camilla Djenne Buarque Müller is a distinguished Brazilian chemist recognized for her impactful contributions to synthetic organic chemistry, natural products chemistry, and medicinal chemistry. She earned her Ph.D. and M.Sc. in Chemistry from the Federal University of Rio de Janeiro (UFRJ), where she conducted innovative research on pterocarpans, aza-pterocarpans, and palladium-catalyzed arylation strategies. Her academic career includes key faculty positions at the Pontifical Catholic University of Rio de Janeiro (PUC-Rio), where she progressed from Assistant Professor to Associate Professor, and currently continues her scientific leadership at Fluminense Federal University (UFF). Prof. Müller has also held important roles within the Brazilian Chemical Society (SBQ), serving as Vice-Secretary and Secretary of SBQ-Rio. Her research interests span heterocyclic synthesis, triazole hybrids, CFTR modulator development, covalent organic frameworks, and structure-activity relationships applied to drug discovery. She has received numerous prestigious honors, including Research Productivity Fellowships (CNPq), Scientist of Our State (FAPERJ), Young Scientist of Our State, Best Poster Awards, and multiple recognitions for excellence in undergraduate and graduate supervision. Prof. Müller continues to advance chemistry through impactful publications, mentorship, and contributions that strengthen Brazil’s scientific community.

Profiles: Scopus | Orcid

Featured Publications

Zeitune, D. C., Azevedo, M. F. M. F., Rangel, M. S., Bastos, R. de S., Neto, J. de B. V., Pessoa, C. do Ó., & Buarque, C. D. (2025). Synthesis and antitumoral activity of novel biaryl hydroxy-triazole and fluorene-triazole hybrids. Exploration of Drug Science.

Carneiro, L. S. A., & Buarque, C. D. (2025). Arylation of C=C bonds via non-cross-coupling reactions: historical evolution of the Meerwein arylation mechanisms. ChemTexts.

Azevedo, M. F. M. F., Zeitune, D. C., de Farias, R. L., Junior, E. N. C., Bacalhau, M., Amaral, M. D., Lopes-Pacheco, M., & Buarque, C. D. (2025). Direct access of 4-acyl-1,2,3-triazoles from acetophenones: A synthetic shortcut for novel p.Phe508del-CFTR traffic correctors. Journal of Molecular Structure.

Bacalhau, M., Ferreira, F. C., Azevedo, M. F. M. F., Rosa, T. P., Buarque, C. D., & Lopes-Pacheco, M. (2025). Rescue of mutant CFTR channel activity by investigational co-potentiator therapy. Biomedicines.

Cifuentes, J. M. C., Henrique, F. J. F. S., Ligiéro, C. B. P., Esteves, P. M., & Buarque, C. D. (2024). Covalent organic frameworks as a versatile platform for iron-catalyzed sp³ C–H activation and cross-coupling via decarboxylative oxidation. European Journal of Inorganic Chemistry.

Ferreira, F., Buarque, C., & Lopes-Pacheco, M. (2024). Organic synthesis and current understanding of the mechanisms of CFTR modulator drugs Ivacaftor, Tezacaftor, and Elexacaftor. Molecules.

da Silva, V. D., Zalewska, K., Petrovski, Z., Buarque, C. D., Branco, L. C., & Esteves, P. M. (2023). Covalent organic frameworks as promising materials for the removal of metal and organic pollutants from water. Materials Today Sustainability.

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Published on by Research Chemistry Awards

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Changzhou University | China

Dr. Hongyan Lin is a distinguished researcher and lecturer at the School of Pharmaceutical Sciences, Changzhou University, China, with a strong emphasis on natural product chemistry and molecular pharmacology. She completed her Bachelor’s degree in Bioengineering at Changzhou University, followed by an Integrated Master-PhD in Biology at Nanjing University, where she specialized in the biological mechanisms of traditional medicine. Dr. Lin further expanded her expertise as a Postdoctoral Fellow and Research Associate at the School of Life Sciences, Nanjing University, contributing significantly to molecular pharmacology and natural product research. Her research interests focus on the chemical structural modification of natural products for anticancer applications, the role of traditional Chinese medicine in regulating intestinal microbiota to prevent colitis-associated cancer, and the isolation, structural identification, and biological activity of bioactive compounds from traditional herbs. Dr. Lin has been recognized for her scientific contributions through research grants and academic publications in high-impact journals. Her work supports the evolution of natural product-based therapeutics and offers promising directions for cancer prevention and treatment. In her role as a lecturer and researcher, she continues to inspire the next generation of pharmaceutical scientists through her dedication and innovation.

Profiles: Scopus | Orcid

Featured Publications

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products, Published online July 28, 2023.

Lin, H., Zhou, Z., Ma, X., Chen, Q., Han, H., Wang, X., Qi, J., & Yang, Y. (2021). One pot synthesis of aryl nitriles from aromatic aldehydes in a water environment. RSC Advances, 2021.

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Published on by Research Chemistry Awards

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Wuhan University - China

Author Profile

Early Academic Pursuits

Ms. Yufang Ma's academic journey began with a fervent interest in the biomedical sciences. She completed her undergraduate studies with a focus on pharmacology, where she developed a strong foundation in understanding drug interactions and biological systems. Her early research interests centered around natural compounds, particularly flavonoids, which are known for their diverse pharmacological properties. This interest led her to delve deeper into the conformational relationships of these compounds, exploring how their structures influence their biological activities. Her dedication to her studies was reflected in her academic excellence and active participation in various research initiatives.

Professional Endeavors

Following her undergraduate studies, Ms. Yufang Ma pursued a Master's degree at Wuhan University, one of the top institutions in China. Her professional endeavors have been marked by her commitment to advancing pharmacological research. At Wuhan University, she has been primarily engaged in studying the conformational relationships of flavonoids and their pharmacological effects. Her research aims to uncover the therapeutic potential of these natural compounds, particularly in the context of treating neurological disorders such as epilepsy. This work not only contributes to the scientific community's understanding of flavonoids but also has the potential to lead to the development of new, effective treatments for epilepsy.

Contributions and Research Focus

Ms. Yufang Ma's contributions to pharmacological research are centered on her in-depth studies of flavonoids. Her primary research focus involves investigating the conformational relationships of these compounds and how their structural variations impact their pharmacological properties. She is particularly interested in the therapeutic potential of flavonoids in treating epilepsy, a neurological disorder characterized by recurrent seizures. Through her research, she aims to identify specific flavonoids that can modulate neuronal activity and reduce seizure frequency. This focus on epilepsy research is a significant contribution to the field, as it addresses a critical need for new, effective treatments for this debilitating condition.

Accolades and Recognition

While Yufang Ma's work is ongoing, she has already garnered recognition for her contributions to pharmacological research. Her dedication to exploring the therapeutic potential of flavonoids has been acknowledged by her peers and mentors at Wuhan University. Although she has not yet published extensively or secured patents, her research on epilepsy is paving the way for significant advancements in the field. The recognition she has received serves as a testament to her potential to make impactful contributions to pharmacology and therapeutics.

Impact and Influence

The impact of Yufang Ma's research extends beyond the academic community. Her work on flavonoids and epilepsy has the potential to influence the development of new pharmacological treatments. By identifying specific flavonoids with anticonvulsant properties, her research could lead to the creation of novel therapies that offer better efficacy and fewer side effects compared to existing treatments. This potential impact highlights the broader significance of her work in improving patient outcomes and enhancing the quality of life for individuals with epilepsy.

Legacy and Future Contributions

Ms. Yufang Ma's legacy in pharmacological research is still in the making, but her ongoing work promises to leave a lasting impact on the field. As she continues to explore the therapeutic potential of flavonoids, her findings could pave the way for new treatment paradigms in epilepsy and other neurological disorders. Her future contributions are likely to extend beyond research, potentially influencing clinical practices and drug development strategies. With her dedication and innovative approach, Ms. Yufang Ma is poised to become a leading figure in pharmacology, contributing to the advancement of science and the improvement of human health.

Notable Publication

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity, 2024.

Diosmetin Ameliorates HFD-induced Cognitive Impairments via Inhibiting Metabolic Disorders, Mitochondrial Dysfunction and Neuroinflammation in Male SD Rats, 2024